InhaleRx Balance Sheet Health
Financial Health criteria checks 5/6
InhaleRx has a total shareholder equity of A$665.5K and total debt of A$560.3K, which brings its debt-to-equity ratio to 84.2%. Its total assets and total liabilities are A$1.6M and A$911.4K respectively.
Key information
84.2%
Debt to equity ratio
AU$560.28k
Debt
Interest coverage ratio | n/a |
Cash | AU$715.82k |
Equity | AU$665.47k |
Total liabilities | AU$911.41k |
Total assets | AU$1.58m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: IRX's short term assets (A$1.6M) exceed its short term liabilities (A$911.1K).
Long Term Liabilities: IRX's short term assets (A$1.6M) exceed its long term liabilities (A$291.0).
Debt to Equity History and Analysis
Debt Level: IRX has more cash than its total debt.
Reducing Debt: IRX's debt to equity ratio has increased from 0% to 84.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: IRX has sufficient cash runway for 4 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: IRX is forecast to have sufficient cash runway for 4 months based on free cash flow estimates, but has since raised additional capital.